Study of sarcoma care quality across Europe and Latin America
Part of Bones, joints & muscles, Cancer, Digestive system clinical trials.
This observational study looks at information from people with sarcoma to understand how care is delivered across different centers. It does not test a new treatment, but may help improve future care and planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a confirmed diagnosis of soft-tissue sarcoma, GIST, or bone sarcoma
- Be at least 18 years old
- Have medical and treatment records available for the study
- Have been diagnosed at any time from January 2005 through about September 2023
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with soft tissue sarcoma take part in clinical trials. By joining, you help researchers learn more about trial participation, which may lead to better access to new treatments for others.
This study looks at immune system “fingerprints” using tumor tissue from people with rare soft tissue sarcoma. It may help researchers understand what drives these cancers and guide future treatments.
This study looks at how closely patients in the Strasbourg area follow their sarcoma treatment plans and how that affects their survival. Sarcoma is a rare type of cancer that starts in the body's connective tissues, like fat, muscle, or blood vessels.
This study looks at the quality of life and medical care for people who have had sarcoma (including soft tissue, bone, or GIST) for at least 5 years. It aims to understand how survivors are doing and how their care can be improved.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This study tests whether adding palliative care early on to standard cancer treatment improves quality of life for people newly diagnosed with advanced or metastatic soft tissue sarcoma.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.